![The American contingent and Turkey’s autonomy goals: Paris Air Show Day 3 [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/Wednesday-Wrap.00_00_32_21.Still001.png?#)
![A look at the jets flying high above the Paris Air Show [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/Rafale_02-scaled-e1750268097167.jpg?#)
FDA Approves Yeztugo (lenacapavir) as the First and Only HIV Prevention Option Offering 6 Months of Protection
FOSTER CITY, Calif.--(BUSINESS WIRE) June 18, 2025 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir)—the company’s injectable HIV-1 capsid...
FOSTER CITY, Calif.--(BUSINESS WIRE) June 18, 2025 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir)—the company’s injectable HIV-1 capsid...
